about
Blinding trachoma: a disease of povertyPsychiatric health laws in Pakistan: from lunacy to mental healthPrognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epitheliumMicroRNA signature characterizes primary tumors that metastasize in an esophageal adenocarcinoma rat modelCardiovascular side effects of atomoxetine and its interactions with inhibitors of the cytochrome p450 systemAcute health effects of the Tasman Spirit oil spill on residents of Karachi, Pakistan.Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan.Thrombotic thrombocytopenic purpura and gemcitabine.The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study.Establishing magnetic resonance imaging as an accurate and reliable tool to diagnose and monitor esophageal cancer in a rat modelIncidence, management, and outcome of molar pregnancies at a tertiary care hospital in quetta, pakistanChemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer.Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma.Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective.Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.Coping styles in patients with anxiety and depressionSafety of pegfilgrastim (neulasta) in patients with sickle cell trait/anemia.Gallbladder agenesis.Chemotherapy Maintenance.A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome.Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets.Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.Treatment of HIV/AIDS associated cancers with immunotherapy targeting PD-1/PD-L1 instead of chemotherapy.Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.Mutational burden on circulating cell-free tumor-DNA testing as a surrogate marker of mismatch repair deficiency or microsatellite instability in patients with colorectal cancers.The use of intravenous neostigmine in palliation of severe ileusAortic dissection and renal failure in a patient with severe hypothyroidismNelarabine associated myotoxicity and rhabdomyolysis.Rituximab and cytokine release syndrome.Birt-hogg-dubé syndrome: answering questions raised by a case report published in 1962.The role of fine-needle aspiration cytology in the diagnosis of Basal cell carcinoma.Correlates of morbidity and mortality in severe necrotizing pancreatitis.Excessive work hours of physicians in training: maladaptive coping strategies.Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan.Trachoma still ignored in developing countries.Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension.Neuroendocrine Tumor Involving the Epicardium.Quintuplets born to a woman without fertility treatment in Pakistan.Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation-associated metastatic renal-cell carcinoma.
P50
Q24796784-86DFDE43-AD1E-4C2E-BF54-AFF288581D04Q24814504-90F8A44A-0225-46A9-B2CD-2D4BD8E88A6DQ28390556-0D788147-B018-4309-B674-9499607AC216Q28390889-0D52424A-4E13-46F1-8A5F-06A23D8A6372Q33160256-F9785638-C2FD-4FE8-A2B0-9F1FE4539B3CQ33238493-A2C29298-01C8-48FC-BEBB-A347721AC563Q33380180-5132DBC8-B569-458A-934A-0546441CD229Q33395859-32E1C2BE-8E82-4C4D-8260-774035FFE7EDQ33785811-72339DE7-BC04-4A1A-A72D-026FFEB53930Q35140276-BBFA8A89-8BCE-426A-9AFA-B19117DE922DQ35370988-6DE1D1DC-A610-466B-9BD1-A4304AE49256Q35680674-F626AEE6-F8BF-4926-9F08-DD58363865C7Q35913735-A659FCAF-E8EC-4D68-BB9B-E87340CC8B5FQ36076767-E7714813-6E54-4D4F-A9B2-37B272A850B1Q36633769-B3C3D101-CB2D-432F-8742-13D6561125FAQ36813582-C7EA71A9-9A5A-48FB-AAE7-56A173DB7194Q36857606-17B4CE1B-56FF-44FB-A4CF-18784075ED9DQ37417406-E3D7366B-A38B-41A4-A2C0-3F462CCFABAFQ37973338-A75739F7-9669-41C3-8EF1-C94B56EFA486Q38876077-6702F6F7-07B5-42DD-8FFB-E361C3D84E43Q39192174-1FFF1AA4-AEC7-421C-89D0-75C06955DCC1Q39977197-012B5CDA-7828-4F97-8AA8-ED3DA6865A77Q40209192-0E8527B8-C318-4D0D-9AC3-9C6EE309040AQ40913303-E143C3EF-39DB-4924-AD77-AECCCD7ED5B4Q40981383-88844C7C-823B-419B-823A-86B350DE3DCAQ41598555-AAA1622D-AD68-4AD0-9D0E-DA055F94ED95Q41673153-962F1D0A-B4D3-4225-B5E7-CFB3ABADEED9Q41771166-0174B5F3-0421-4FC8-BC8A-376C549B08DFQ41847188-E8DE7D2C-FEDC-4296-8298-272940654274Q41859216-0606A699-E3D8-441D-9729-0FB48B89B7D5Q41969310-120F8F6D-1B25-4653-9761-45BA10073D80Q42031123-2A24CFB8-6FFC-464E-8FBD-D3998090C115Q42242446-F142B25A-8D50-484A-A121-7B4BC787B93CQ42348049-EF334349-86FA-4050-BC87-2E1B94CBB098Q43036327-2AA37657-96ED-45E8-B717-985688DCCC5DQ43311413-D4CD72B4-63AF-40A8-B097-EF49BC06B346Q49896965-BA29FA8E-0F36-4062-B535-E51851B4ED40Q50073519-5EEC94B6-D6E6-4185-A02B-8A718EF27F81Q50777618-6AAF2B60-19FF-4394-ADE2-6F42AE89A591Q52334009-4B584BE6-38ED-488F-AA71-B011A743CA27
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pashtoon Murtaza Kasi
@ast
Pashtoon Murtaza Kasi
@en
Pashtoon Murtaza Kasi
@es
Pashtoon Murtaza Kasi
@sl
type
label
Pashtoon Murtaza Kasi
@ast
Pashtoon Murtaza Kasi
@en
Pashtoon Murtaza Kasi
@es
Pashtoon Murtaza Kasi
@sl
prefLabel
Pashtoon Murtaza Kasi
@ast
Pashtoon Murtaza Kasi
@en
Pashtoon Murtaza Kasi
@es
Pashtoon Murtaza Kasi
@sl
P106
P1153
6507870398
P2798
P31
P496
0000-0002-5169-7085